QUATTRO TEAM

FOCUSED TEAMS WITH EXPERT LEADERSHIP

We sometimes like to think of Quattro as a Special Forces team for growth. We are not for every mission. However, if you have a vital growth challenge, you have come to the right place. That’s all we do.

ANN COLISTER

FOUNDER + MANAGING DIRECTOR

ANN COLISTER

FOUNDER + MANAGING DIRECTOR

Ann is a co-founder and Managing Director of Quattro Consulting Inc. For over twenty-five years, Ann has been immersed in helping clients answer their most critical growth questions. She has had an essential role in fostering the company’s rigorous and creative in-depth approach to answering complex growth, strategy, and investment questions facing life sciences companies from Fortune 500 firms to start-ups and hedge funds. On behalf of Quattro clients, Ann has personally interviewed thousands of physicians, distilling insights from divergent opinions inherent in medicine. This experience has provided her with an exceptional perspective on physician motivations and behavior. Combined with this, Ann has led the development and analyses of hundreds of surveys and disease state/product models covering a vast range of opportunity assessments. Expert at marrying deep qualitative insights with quantitative market models, Ann’s work and leadership of Quattro teams have helped client companies overcome challenges, capture opportunities, predict growth, and formulate actions to drive it.

Before founding Quattro, Ann worked as a consultant in Bain & Company’s healthcare practice. Prior to her healthcare growth strategy focus, she was a Captain and Company Commander in the US Army. Ann has the unique distinction of being a member of the first class of women to graduate from the United States Military Academy at West Point. She holds a BS in Engineering from West Point and an MBA from Stanford University.

DAVID BLUESTEIN, MD

PRINCIPAL

DAVID BLUESTEIN, MD

PRINCIPAL

David Bluestein, MD, is a distinguished urologist with a wealth of experience in the medical field. With a career marked by excellence and leadership, Dr. Bluestein has made significant contributions to healthcare as both a practitioner and an administrator.

Following the completion of his medical degree at the University of California, Los Angeles, and his residency training at the Mayo Clinic in Rochester Minnesota, Dr. Bluestein embarked on a journey dedicated to providing exceptional urological care. Through extensive training and hands-on experience, he developed a deep understanding of urological conditions and treatments earning him the trust and respect of patients and colleagues alike. Dr. Bluestein continually sought out state-of-the-art medical therapies and cutting-edge technology to advance the care of his patients.

Dr. Bluestein’s dedication to excellence propelled him into leadership roles within the medical community. He served as the President of Pine Ridge Surgery Center, where his strategic vision and commitment to patient care elevated the standard of surgical services provided. Under his leadership, the center successfully integrated four different surgical specialties, navigated the complexities of insurance reimbursement, and implemented advanced technologies at the facility.

Additionally, Dr. Bluestein held the position of President at Urology Specialists of Wisconsin, where he led a team of talented professionals in delivering exceptional urological care to patients across the region. His leadership was characterized by a patient-centered approach, a commitment to excellence, and a passion for advancing medical knowledge and technology in the field of urology. Dr. Bluestein also gained an understanding of the hospital perspective on implementing medical breakthroughs into the workplace, having sat on multiple medical staff Boards.

Driven by a desire to broaden his impact and share his expertise, Dr. Bluestein joined Quattro Consulting, where he continues to lend his input and guidance to biopharma and medtech industries. His wealth of experience, coupled with his strategic acumen, makes him a valuable asset to organizations striving to navigate the complexities of the healthcare market.

Beyond his professional achievements, Dr. Bluestein is an avid skier and mountain biker and has completed the Leadville 100 mountain bike race twice.

STAN DERESINSKI,
MD FACP FIDSA

CHIEF MEDICAL ADVISOR

DR. STANLEY DERESINSKI,
MD, FACP

CHIEF MEDICAL ADVISOR

Dr. Stan Deresinski is Clinical Professor of Medicine at Stanford University School of Medicine in Palo Alto, California in the Division of Infectious Diseases and Geographic Medicine as well as Medical Director of the Antimicrobial Stewardship Program.

Dr. Deresinski received his medical degree from the University of Illinois College of Medicine, where he also completed two years of training in Internal Medicine. His training was then interrupted by 2 years of U.S. Army service, starting with a tour in Vietnam. He completed his Internal Medicine residency at Stanford University where he then received 3 years of training in Infectious Diseases. His career and experience have been long and varied. In addition to serving as a physician in the military, he has worked at Veterans Administration hospital and a public county hospital, as well as at both a university hospital and a private community hospital.

He maintained a private practice in Infectious Disease, HIV, and Travel Medicine in Redwood City, California and was Hospital Epidemiologist at Sequoia Hospital where he served as President of the Medical Staff for 2 years. During most of that time he was also Associate Chief of the Division of Infectious Diseases and Director of the AIDS Program at the Santa Valley Medical Center. In 1987, he founded the AIDS Community Research Consortium, serving as its Medical Director and Chairman of the Board for almost 2 decades. He was also Site Principal Investigator for the Stanford AIDS Clinical Trials Unit and the California Collaborative Treatment Group. Dr. Deresinski is currently Clinical Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine at Stanford and is Medical Director of the Stanford Antimicrobial Stewardship Program as well as Chair of the Pharmacy and Therapeutics Committee.

In addition to multiple book chapters, Dr. Deresinski has published more than 140 peer-reviewed articles dealing with a broad range of infectious. He has also been Editor of Infectious Disease Alert since 1992 and Section Editor of Clinical Infectious Diseases since 2005. In addition, he has served as a consultant to industry.

Dr. Deresinski is a Fellow of the American College of Physicians, the Infectious Diseases Society of America (IDSA), and the European Society of Clinical Microbiology and Infectious Diseases.

He has also received the Certificate of Knowledge in Clinical Tropical Medicine and Travelers Health from the American Society of Tropical Medicine and Hygiene and is a member of the HIVMA and SHEA. He was a member of the IDSA Standards and Practice Guidelines Committee (SPGC) from 2005-2008 and then served as Chair of that committee from 2005-2008. Dr. Deresinski was a member of the IDSA Board of Directors from 2012-2015. He is a past member of the Society of Healthcare Epidemiologists of America (SHEA) Antimicrobial Stewardship Committee and is a current member of the Advisory Committee of the Antimicrobial Stewardship Program of the Center for Infectious Disease Research and Policy (CIDRAP). He recently served on an expert panel dealing with antimicrobial resistance for the General Accounting Office in response to a request from Congress.

Dr. Deresinski has also recently served on the HICPAC working group addressing the issue of incorporation of stewardship principles into IDSA guidelines as well as a CDC external expert dealing with development and implementation of the Standardized Antimicrobial Administration Ratio (SAAR), a metric designed to allow comparison of antimicrobial use at institutions throughout the U.S. Dr. Deresinski has received a number of teaching awards at Stanford and is a past recipient of the Watanakunakorn Award given by the Infectious Diseases Society of America (IDSA) to the best clinician of the year.

Dr. Deresinski established the Stanford Antimicrobial Safety and Sustainability (SASS) program in 2012 (http://med.stanford.edu/bugsanddrugs.html). The program has developed multiple online courses dealing with antimicrobials, one of which has been accessed by more than 130,000 registrants from more than 120 countries. Most recently, the group has created a case-based online course for the World Health Organization (WHO) designed to educate providers throughout the world regarding antimicrobial stewardship. SASS has been named as a Center of Excellence by the IDSA and has also been designated a WHO Centre of Excellence for Antimicrobial Resistance and Stewardship.

PROJECT TEAM STRUCTURE

PROJECT TEAM STRUCTURE

Quattro teams, typically five to seven members, are led by only our most experienced people.

Having been in healthcare for decades, our founders know this industry. They personally lead Quattro’s analytic process, immersed from initial planning to project completion. Our leaders are not arms-length. On-target execution demands on-point project leadership.